YS Ma, LK Hou, SH Yao, JB Liu, XC Yu, Y Shi… - Molecular Therapy …, 2021 - cell.com
Drug resistance is a key factor in the treatment failure of clinical non-small cell lung cancer
(NSCLC) patients after adjuvant chemotherapy. Here, our results provide the first evidence …